|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 7/56 | |
| C07K 14/81 | |||
| A61K 38/12 |
| (11) | Patento numeris | 2183270 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08803037.4 |
| Europos patento paraiškos padavimo data | 2008-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-05-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/060693 |
| Data | 2008-08-14 |
| (87) | Numeris | WO 2009/024528 |
| Data | 2009-02-26 |
| (30) | Numeris | Data | Šalis |
| 07114505 | 2007-08-17 | EP |
| (72) |
KRASTEL, Philipp, DE
LIECHTY, Brigitta-Maria, CH
SCHMITT, Esther, DE
SCHREINER, Erwin Paul, AT
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 |
| USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 |